Table 4

Multivariate area under receiver operating characteristic data for predicting various outcomes from baseline bloods

BiomarkerPatients
(N)
Cases
(N)
D.F.AUC
(95% CI)
Bootstrap
30-day mortality
 MR-proADM1353050.874 (0.8085 to 0.9395)0.01727
 CRP1353050.8441 (0.769 to 0.9192)0.1464
 PCT1162650.8406 (0.7619 to 0.9193)0.06908
 Neutrophils1353050.8394 (0.7667 to 0.9121)0.1417
 Lymphocytes1353050.8448 (0.7716 to 0.918)0.1056
Critical care admission
 MR-proADM1353150.7466(0.6553 to 0.8379)0.1457
 CRP1353150.8026 (0.7256 to 0.8796)0.012
 PCT1163150.7632 (0.6747 to 0.8517)0.1465
 Neutrophils1353150.7252 (0.6359 to 0.8145)0.2458
 Lymphocytes1353150.7317 (0.6413 to 0.8221)0.2132
NIV
 MR-proADM1352350.8544 (0.7727 to 0.9362)0.000375
 CRP1352350.8139 (0.7374 to 0.8904)0.001052
 PCT1162250.7872 (0.6884 to 0.8861)0.03331
 Neutrophils1352350.7418 (0.6341 to 0.8496)0.07907
 Lymphocytes1352350.7519 (0.6461 to 0.8578)0.05353
Intubation and ventilation
 MR-proADM1351650.812 (0.7071 to 0.9169)0.005858
 CRP1351650.8183 (0.7176 to 0.9189)0.002934
 PCT1161650.7256 (0.6193 to 0.8319)0.1324
 Neutrophils1351650.6817 (0.576 to 0.7874)0.2557
 Lymphocytes1351650.6838 (0.5664 to 0.8012)0.2675
  • AUC, area under the curve; CRP, C reactive protein; D.F., Degrees of Freedom; MR-proADM, mid-regional proadrenomedullin; NIV, non-invasive ventilation; PCT, procalcitonin.